SCHEMBL5819926

SCHEMBL5819926

Cc1c(C(C)C(=O)OC2CCC2)c2c(F)c(O)ccc2n1C(=O)c1cccc(Cl)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.37
PTGS2 P35354 1/20 0.36
HSD11B1 P28845 1/20 0.36
CNR1 P21554 1/20 0.35
CNR2 P34972 1/20 0.35
ALDH1A1 P00352 1/20 0.34
PDE4B Q07343 1/20 0.34
IDO1 P14902 1/20 0.34
GRM5 P41594 2/20 0.34
CHRNA1 P02708 1/20 0.33
CHRNG P07510 1/20 0.33
CHRNB1 P11230 1/20 0.33
CHRNB2 P17787 1/20 0.33
SLC6A2 P23975 1/20 0.33
CHRNB4 P30926 1/20 0.33
SLC6A4 P31645 1/20 0.33
CHRNA3 P32297 1/20 0.33
CHRNA4 P43681 1/20 0.33
SLC6A3 Q01959 1/20 0.33
CHRND Q07001 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5800993 0.98 PTGS2 (0.37) L3MBTL1PTGS2HSD11B1CNR1CNR2
SCHEMBL5822711 0.91 LMNA (0.39) HSD11B1ALDH1A1CHRNB2SLC6A2CHRNB4
SCHEMBL5800837 0.90 L3MBTL1 (0.37) L3MBTL1PTGS2HSD11B1CNR1CNR2
SCHEMBL5797992 0.90 LMNA (0.39) HSD11B1ALDH1A1CHRNB2SLC6A2CHRNB4
SCHEMBL5559333 0.90 PTGS2 (0.43) PTGS2
SCHEMBL5800295 0.89 TSHR (0.36) PTGS2HSD11B1ALDH1A1TSHR
SCHEMBL5558388 0.89 PTGS2 (0.35) PTGS2HSD11B1ALDH1A1
SCHEMBL5822674 0.88 PTGS2 (0.36) PTGS2TSHR
SCHEMBL5798160 0.88 L3MBTL1 (0.37) L3MBTL1PTGS2HSD11B1CNR1CNR2
SCHEMBL5798701 0.88 PTGS2 (0.45) PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006050120-A2 SYNTHESIS OF COX-2 AND FAAH INHIBITORS MICROBIA, INC. (US) 2006-05-11 WO disclosed
US-20050234244-A1 Synthesis of COX-2 and FAAH inhibitors IRONWOOD PHARMACEUTICALS, INC. 2005-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050234244-A1 Synthesis of COX-2 and FAAH inhibitors FAAH2, FAAH, PTGES2 L3MBTL1 4595/4885PTGS2 4/4885HSD11B1 1120/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.